Register Now
Panelists:
Yvete Toivola, PhD
VP, Product ManagementFlywheel
View Bio
Panelist
Yvete Toivola, PhD
Yvete Toivola, PhD, is the vice president of Product Development at Flywheel, where she leads the development of imaging-centered data platforms that support rigorous scientific and clinical research. An engineer by training, she has over 20 years of research-intensive product development experience across microelectronics, data storage, and medical devices. Toivola focuses on translating deep scientific and engineering principles into secure, scalable software that enables AI-ready workflows and post-trial data access. She is recognized for bridging scientific rigor with practical product strategy to help researchers and life sciences teams accelerate meaningful therapeutic discovery.
Close
Daniel J. Rafter, MD
SVP, Partner & Product StrategyFlywheel
View Bio
Panelist
Daniel J. Rafter, MD
Daniel Rafter, MD, is the senior vice president of Partner & Product Strategy at Flywheel, where he leads global initiatives with hyperscalers, technology innovators, and life sciences organizations to accelerate imaging-driven research and AI development. With a background in Neuro Critical Care research and medical software strategy, Rafter bridges clinical insight and enterprise technology to advance Flywheel’s mission of enabling scientific discovery through structured, compliant, and AI-ready data.
Close
Elif Sikoglu, PhD
Senior Medical DirectorPerceptive Imaging
View Bio
Panelist
Elif Sikoglu, PhD
Elif Sikoglu, PhD, is a senior director at Perceptive, a leading imaging provider for clinical trials. Sikoglu is an imaging scientist with more than 20 years of expertise, particularly focusing on advanced imaging approaches within CNS clinical trials across multiple phases and indications. Prior to joining Perceptive, she was a postdoctoral research associate in the Psychiatry Department at UMass Medical School, where she worked on establishing novel imaging biomarkers using functional MRI, Diffusion Tensor Imaging, and MR Spectroscopy in mood disorders and TBI. Her work also focuses on effective technology utilization, the integration of quantitative biomarkers and AI within the clinical trial framework.
Close
Broadcast Date: Tuesday, February 17, 2026Time: 08:00 PST, 11:00 EST, 16:00 GMTClinical trials generate terabytes of imaging data—details on disease status, treatment effects, and progression—but biopharma sponsors don’t see most of it. They typically receive summarized outputs from clinical research organizations (CROs), while the underlying imaging data, including quality metrics and annotations, remain locked in closed systems across multiple sites. This is a problem for drug developers who are increasingly interested in studying primary data. And it explains why some are investing in data ecosystems that serve as the foundation for AI tools to make their images findable and usable.In this GEN webinar, experts from Perceptive Imaging and Flywheel explore how imaging data access issues slow decision-making and increase risks for both biopharma and CROs. Case studies drawn from oncology and neurology trials show how earlier streamlined access to patient images using AI and cloud infrastructure can shorten turnaround times for decisions like determining patient eligibility, enable complex analyses during and after the trial, and support future protocol design. Key takeaways include:Why imaging data is handled differently than other types of clinical data, contributing to delays in sponsor access and secondary analysisHow compliant imaging workflows enhance data governance, accelerate trial timelines, support regulatory readiness, and facilitate secondary data reuseHow Flywheel’s imaging data management solution provides shared access to raw data in a controlled, auditable environment that meets GxP, HIPAA, and 21 CFR Part 11 requirementsA live Q&A session will follow the presentations, offering you a chance to pose questions to our expert panelists.Produced with support from:The post Improving Biopharma Sponsor Access to Clinical Trial Imaging Data appeared first on GEN – Genetic Engineering and Biotechnology News.
